Hello! This is April 18, 2025.

Supreme Court Reviews Trump’s Birthright Citizenship Order

The Supreme Court is preparing to hear major arguments over President Trump’s executive order to end birthright citizenship. This order challenges long-standing interpretations of the 14th Amendment and aims to stop automatic citizenship for children born to illegal immigrants. Three federal courts had blocked the order, but the administration is now fighting to reinstate it with a narrowed focus. The case could reshape the future of immigration policy and constitutional law in America.

Rubio: U.S. May Quit Ukraine Peace Talks

Secretary of State Marco Rubio warned the U.S. might walk away from peace talks between Russia and Ukraine if no progress is made soon. After days of intense diplomacy, the Trump administration says it’s time to decide whether peace is even possible. Despite multiple high-level meetings and efforts, Russia continues to reject a full ceasefire unless Ukraine stops mobilizing troops and receiving Western weapons. With pressure mounting, a final decision on continuing talks could come in just days.

Trump Blasts Senator Over MS-13 Suspect Meeting

President Trump called out Senator Chris Van Hollen for traveling to El Salvador to meet with a deported MS-13 suspect. The visit drew national attention after the senator claimed the man was wrongly deported, while new court documents revealed domestic abuse allegations from the suspect’s wife. Despite orders from courts to return the man for proper hearings, Trump officials say the removal was justified based on gang ties. The visit has sparked intense debate over immigration enforcement, judicial overreach, and national security priorities.

BlackRock Says 60/40 Retirement Strategy Is Outdated

BlackRock CEO Larry Fink is urging retirees to rethink the traditional 60/40 stock-bond investment mix. With market volatility and inflation pressures rising, Fink suggests shifting toward a 50/30/20 split—adding private assets like real estate and infrastructure for more stability. Even small allocations in these areas can offer reliable income and shield portfolios from market swings. This marks a major shift in how Americans may need to prepare for retirement in today’s changing economy.

Fed Says Uncertainty Not Hurting Economy Yet

Federal Reserve official Mary Daly says uncertainty around Trump-era policies hasn’t slowed down the U.S. economy. Despite market jitters, Daly reports that Americans and businesses are still spending and staying active. With inflation cooling under steady Fed pressure, there’s no urgent need to change interest rates. Her message suggests confidence remains strong even with ongoing political and financial shakeups.

Lilly’s Weight Loss Pill Shows Promising Results

Eli Lilly’s new pill, orforglipron, helped patients lose nearly 8% of their body weight in a major clinical trial. This oral medication also lowered blood sugar in people with Type 2 diabetes, showing promise as a powerful new treatment. Unlike current injected options, this is a small molecule drug taken by mouth, making it easier to use. With approval plans underway, the company is already preparing supplies for global distribution.

New Parkinson’s Drug Shows Major Trial Success

A new once-daily pill called tavapadon is showing big promise for treating Parkinson’s disease with fewer side effects than traditional meds. In clinical trials, patients taking the drug had longer relief from stiffness, tremors, and movement issues without common problems like hallucinations or blood pressure swings. Unlike the older levodopa treatment that must be taken multiple times a day, tavapadon targets different dopamine receptors and works with just one daily dose. Experts say this breakthrough could bring a major shift in how Parkinson’s is treated at all stages of the disease.